Eric Olson

Array ( [id] => 10161297 [patent_doc_number] => 09192507 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Tissue crosslinking for treatment of snoring and obstructive sleep apnea' [patent_app_type] => utility [patent_app_number] => 13/704220 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6683 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13704220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273716 [patent_doc_number] => 08637648 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-01-28 [patent_title] => 'Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier' [patent_app_type] => utility [patent_app_number] => 13/165642 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11731 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13165642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515529 [patent_doc_number] => 08039601 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-10-18 [patent_title] => 'Crystalline forms of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosyloxy)-phenyl] hexane' [patent_app_type] => utility [patent_app_number] => 13/159875 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16058 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039601.pdf [firstpage_image] =>[orig_patent_app_number] => 13159875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7580239 [patent_doc_number] => 20110294122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-01 [patent_title] => 'Synthesis of 2\', 3\'-Dideoxynucleosides for Automated DNA Synthesis and Pyrophosphorolysis Activated Polymerization' [patent_app_type] => utility [patent_app_number] => 13/117029 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11467 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0294/20110294122.pdf [firstpage_image] =>[orig_patent_app_number] => 13117029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043505 [patent_doc_number] => 20120071498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'THERAPEUTIC COMPOSITION TO TREAT LESIONS CAUSED BY HERPES SIMPLEX VIRUS' [patent_app_type] => utility [patent_app_number] => 13/116112 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3467 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071498.pdf [firstpage_image] =>[orig_patent_app_number] => 13116112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696158 [patent_doc_number] => 20110230432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'COMPOSITIONS AND KITS FOR TREATING INFLUENZA' [patent_app_type] => utility [patent_app_number] => 13/116484 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17487 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230432.pdf [firstpage_image] =>[orig_patent_app_number] => 13116484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490108 [patent_doc_number] => 20120289515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression' [patent_app_type] => utility [patent_app_number] => 13/068946 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8410 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13068946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9518852 [patent_doc_number] => 20140155344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'COMBINATION THERAPY METHODS FOR TREATING PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/701001 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 54748 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13701001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9677164 [patent_doc_number] => 08816074 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => '2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections' [patent_app_type] => utility [patent_app_number] => 13/107713 [patent_app_country] => US [patent_app_date] => 2011-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 14 [patent_no_of_words] => 23874 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090862 [patent_doc_number] => 20110218247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN' [patent_app_type] => utility [patent_app_number] => 13/106697 [patent_app_country] => US [patent_app_date] => 2011-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4304 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218247.pdf [firstpage_image] =>[orig_patent_app_number] => 13106697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8982088 [patent_doc_number] => 08513202 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate' [patent_app_type] => utility [patent_app_number] => 13/103557 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2920 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13103557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977647 [patent_doc_number] => 08071570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 13/103960 [patent_app_country] => US [patent_app_date] => 2011-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15072 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071570.pdf [firstpage_image] =>[orig_patent_app_number] => 13103960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059918 [patent_doc_number] => 08546353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Compounds and combinations' [patent_app_type] => utility [patent_app_number] => 13/102451 [patent_app_country] => US [patent_app_date] => 2011-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12293 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13102451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8660079 [patent_doc_number] => 20130040908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5\' -MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATIONS CONTAINING THESE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/642905 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064899 [patent_doc_number] => 20110201793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'PROCESS FOR PRODUCTION OF GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 13/093100 [patent_app_country] => US [patent_app_date] => 2011-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11651 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201793.pdf [firstpage_image] =>[orig_patent_app_number] => 13093100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500369 [patent_doc_number] => 20110262917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'MODIFIED NUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/090729 [patent_app_country] => US [patent_app_date] => 2011-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7940 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262917.pdf [firstpage_image] =>[orig_patent_app_number] => 13090729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441558 [patent_doc_number] => 20120258174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Methods for Treating Bacterial Infection' [patent_app_type] => utility [patent_app_number] => 13/085585 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8619 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6177485 [patent_doc_number] => 20110178033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE' [patent_app_type] => utility [patent_app_number] => 13/079424 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20606 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20110178033.pdf [firstpage_image] =>[orig_patent_app_number] => 13079424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375807 [patent_doc_number] => 08680071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Compounds and pharmaceutical compositions for the treatment of viral infections' [patent_app_type] => utility [patent_app_number] => 13/077733 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34644 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13077733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487507 [patent_doc_number] => 20110251152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES' [patent_app_type] => utility [patent_app_number] => 13/076552 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40536 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251152.pdf [firstpage_image] =>[orig_patent_app_number] => 13076552 [rel_patent_id] =>[rel_patent_doc_number] =>)